from Canadian Broadcasting Corporation
Sunday, May 2, 2021
COVID-19 vaccine maker Providence says it s leaving Canada after calls for more federal support go unanswered
A volunteer receives an injection in this undated handout image provided by Providence Therapeutics. (Providence Therapeutics/The Canadian Press) The head of a homegrown company behind a promising COVID-19 vaccine says he s ready to pull his company out of Canada and take its product elsewhere after calls for more substantial federal support went unanswered. Brad Sorenson, the CEO of Calgary-based Providence Therapeutics, told CBC News he s had enough of the runaround from federal and provincial governments and he s working with the company s board of directors to move its operations overseas to focus on developing a vaccine for people in the southern hemisphere.
Government of Canada invests in the Vaccine and Infectious Disease Organization indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.
Article content
Q: Where are things at as far as a return to campus for students this fall?
A: It’s imperative that we say what term is going to look like many months before the term arrives. And at the same time, of course, nobody you talk to would be able to say definitively what the pandemic situation is going to be like that long in advance. So we have to be very, very careful.
So having said all of that, we are tending toward being as face-to-face as we can in the fall, while still being cognizant of what the SHA has to say and what the province has to say about necessary health protocols. So we will be making an announcement in the next couple of weeks about what the fall is going to look like more specifically.
From: Innovation, Science and Economic Development Canada
Backgrounder
The Government of Canada has long supported the University of Saskatchewan’s Vaccine and Infectious Disease Organization’s (VIDO) cutting-edge work in the discovery and development of vaccines for some of the world’s most infectious diseases.
The Government of Canada has long supported the University of Saskatchewan’s Vaccine and Infectious Disease Organization’s (VIDO) cutting-edge work in the discovery and development of vaccines for some of the world’s most infectious diseases.
In Budget 2021, the Government of Canada proposed a $59.2-million commitment to VIDO through Western Economic Diversification Canada to support the development of its COVID-19 vaccine candidates and expand its facility in Saskatoon.